Vicore Pharma Holding
8.29
SEK
-3.15 %
Less than 1K followers
VICO
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-3.15%
+11.57%
+0.61%
-1.89%
+5.61%
-50.35%
-72.82%
-42.04%
+64.16%
Vicore Pharma operates in the pharmaceutical industry and focuses on the development of innovative treatments for pulmonary and cardiovascular diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business is global with a primary presence in Europe and North America. Vicore Pharma was founded in 2000 and is headquartered in Gothenburg, Sweden.
Read moreMarket cap
1.94B SEK
Turnover
2.64M SEK
Revenue
109.35M
EBIT %
-177.59 %
P/E
-
Dividend yield-%
-
Financial calendar
22/8
2025
Interim report Q2'25
5/11
2025
Interim report Q3'25
27/2
2026
Annual report '25
All
Webcasts
Press releases
ShowingAll content types
Vicore to Present at the Jefferies Global Healthcare Conference
Vicore presenterar data på 2025 American Thoracic Society International Conference
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools